In contrast to the observations in HBs-tg mice, TIGIT blockade failed to increase ALT levels and induce liver injury in HBs-tg Rag1−/− mice (Fig. 8d, e), suggesting a critical role of adaptive immunity in mediating TIGIT blockade-induced chronic hepatitis. Here, TIGIT is linked to chronic hepatitis.